68Ga-FAPI PET/CT in Patients With Various Types of Cancer
Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the potential usefulness of 68Ga-DOTA/NOTA-FAPI-04 positron emission
tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions
in various types of cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University